Cleared Traditional

K911935 - CARDIAC ELECTROPHYSICAL LEAD SELECTOR

K911935 is the FDA 510(k) clearance for CARDIAC ELECTROPHYSICAL LEAD SELECTOR by Gould, Inc.. It is a Class 2 Cardiovascular device (product code DRR) cleared through the Traditional 510(k) pathway after a 82-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1991
Decision
82d
Days
Class 2
Risk

K911935 is an FDA 510(k) clearance for the CARDIAC ELECTROPHYSICAL LEAD SELECTOR, MODIFIED. Classified as Amplifier And Signal Conditioner, Biopotential (product code DRR), Class II - Special Controls.

Submitted by Gould, Inc. (Valley View, US). The FDA issued a Cleared decision on July 22, 1991 after a review of 82 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2050 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Gould, Inc. devices

Submission Details

510(k) Number K911935 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 01, 1991
Decision Date July 22, 1991
Days to Decision 82 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
43d faster than avg
Panel avg: 125d · This submission: 82d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DRR Amplifier And Signal Conditioner, Biopotential
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRR Amplifier And Signal Conditioner, Biopotential

All 9
Devices cleared under the same product code (DRR) and FDA review panel - the closest regulatory comparables to K911935.
BARD BIOPOTENTIAL AMPLIFIER
K874441 · C.R. Bard, Inc. · Jan 1988
EPC FILTER
K813123 · Codman & Shurtleff, Inc. · Nov 1981
HP MODEL 8880A FILTER
K802686 · Hewlett-Packard Co. · Nov 1980
MODEL 15055A MAINFRAME
K791964 · Hewlett-Packard Co. · Oct 1979
ESIS MODULE
K780043 · Datascope Corp. · Feb 1978
AMPLIFIER MODULE, 78211A ECG
K772132 · Hewlett-Packard Co. · Nov 1977